These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22115732)

  • 1. Increasing recombinant protein production in Escherichia coli K12 through metabolic engineering.
    Waegeman H; De Lausnay S; Beauprez J; Maertens J; De Mey M; Soetaert W
    N Biotechnol; 2013 Jan; 30(2):255-61. PubMed ID: 22115732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iclR and arcA deletions on physiology and metabolic fluxes in Escherichia coli BL21 (DE3).
    Waegeman H; Maertens J; Beauprez J; De Mey M; Soetaert W
    Biotechnol Lett; 2012 Feb; 34(2):329-37. PubMed ID: 22009573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of iclR and arcA knockouts on biomass formation and metabolic fluxes in Escherichia coli K12 and its implications on understanding the metabolism of Escherichia coli BL21 (DE3).
    Waegeman H; Beauprez J; Moens H; Maertens J; De Mey M; Foulquié-Moreno MR; Heijnen JJ; Charlier D; Soetaert W
    BMC Microbiol; 2011 Apr; 11():70. PubMed ID: 21481254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An engineered Escherichia coli having a high intracellular level of ATP and enhanced recombinant protein production.
    Kim HJ; Kwon YD; Lee SY; Kim P
    Appl Microbiol Biotechnol; 2012 May; 94(4):1079-86. PubMed ID: 22173482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced fluorescent properties of an OmpT site deleted mutant of green fluorescent protein.
    Salunkhe SS; Raiker VA; Rewanwar S; Kotwal P; Kumar A; Padmanabhan S
    Microb Cell Fact; 2010 Apr; 9():26. PubMed ID: 20429908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of the reductase deficient Escherichia coli on the solubility of recombinant proteins produced in it].
    Xiong S; Zhang MY; Qian CW; Ran YC; Wang YF; Ren XR; Su KY; Yu ZY
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):686-91. PubMed ID: 15971580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion-dependent proteolysis of heterologous protein by recombinant Escherichia coli is connected to an increased activity of the energy-generating dissimilatory pathway.
    Schmidt M; Viaplana E; Hoffmann F; Marten S; Villaverde A; Rinas U
    Biotechnol Bioeng; 1999; 66(1):61-7. PubMed ID: 10556795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-engineering of an Escherichia coli K-12 strain for the efficient production of recombinant human Interferon Gamma.
    Pandey R; Kumar N; Monteiro GA; Veeranki VD; Prazeres DMF
    Enzyme Microb Technol; 2018 Oct; 117():23-31. PubMed ID: 30037548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of engineered Escherichia coli AF1000 and BL21 strains for (R)-3-hydroxybutyrate production in fed-batch cultivation.
    Perez-Zabaleta M; Guevara-Martínez M; Gustavsson M; Quillaguamán J; Larsson G; van Maris AJA
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5627-5639. PubMed ID: 31104101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG.
    Zhang Z; Kuipers G; Niemiec Ł; Baumgarten T; Slotboom DJ; de Gier JW; Hjelm A
    Microb Cell Fact; 2015 Sep; 14():142. PubMed ID: 26377812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of heterologous thermostable glycoside hydrolases and the presence of host-cell proteases in substrate limited fed-batch cultures of Escherichia coli BL21(DE3).
    Ramchuran SO; Nordberg Karlsson E; Velut S; De Maré L; Hagander P; Holst O
    Appl Microbiol Biotechnol; 2002 Dec; 60(4):408-16. PubMed ID: 12466880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of metabolic limitations during recombinant protein production in Escherichia coli.
    Heyland J; Blank LM; Schmid A
    J Biotechnol; 2011 Sep; 155(2):178-84. PubMed ID: 21723332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of an Escherichia coli strain engineered in the substrate uptake system for improved culture performance at high glucose and cell concentrations: an alternative to fed-batch cultures.
    Lara AR; Caspeta L; Gosset G; Bolívar F; Ramírez OT
    Biotechnol Bioeng; 2008 Mar; 99(4):893-901. PubMed ID: 17929322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a derivative of Escherichia coli BL21(DE3) for efficient production of three different recombinant proteins.
    Zhao JB; Wei DZ
    Biotechnol Prog; 2007; 23(5):1043-8. PubMed ID: 17715940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative reaction engineering studies for succinic acid production from sucrose by metabolically engineered Escherichia coli in fed-batch-operated stirred tank bioreactors.
    Hoefel T; Faust G; Reinecke L; Rudinger N; Weuster-Botz D
    Biotechnol J; 2012 Oct; 7(10):1277-87. PubMed ID: 22588847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.
    Yildirim S; Konrad D; Calvez S; Drider D; Prévost H; Lacroix C
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):525-31. PubMed ID: 17882416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fermentation of xylose to succinate by enhancement of ATP supply in metabolically engineered Escherichia coli.
    Liu R; Liang L; Chen K; Ma J; Jiang M; Wei P; Ouyang P
    Appl Microbiol Biotechnol; 2012 May; 94(4):959-68. PubMed ID: 22294432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
    Shin CS; Hong MS; Bae CS; Lee J
    Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of a recombinant phospholipase A2 in Escherichia coli using resonant acoustic mixing that improves oxygen transfer in shake flasks.
    Valdez-Cruz NA; Reynoso-Cereceda GI; Pérez-Rodriguez S; Restrepo-Pineda S; González-Santana J; Olvera A; Zavala G; Alagón A; Trujillo-Roldán MA
    Microb Cell Fact; 2017 Jul; 16(1):129. PubMed ID: 28743267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucose supply strategy on acetate accumulation, growth, and recombinant protein production by Escherichia coli BL21 (lambdaDE3) and Escherichia coli JM109.
    Shiloach J; Kaufman J; Guillard AS; Fass R
    Biotechnol Bioeng; 1996 Feb; 49(4):421-8. PubMed ID: 18623597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.